Research location
Clementon
New Jersey, United States
Advertisement
Research activity in Clementon
New Jersey, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 63 trials and 64 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Clementon
63 linked trials · page 1 of 2A Phase 1 Safety Study in Adults With SchizophreniaNCT02804568 · 2016-06-01 · 1 site observation
COMPLETED
A Study of CX157 (TriRima) for the Treatment of DepressionNCT00739908 · 2008-09-01 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With SchizophreniaNCT00772005 · 2008-09-01 · 1 site observation
COMPLETED
A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe DepressionNCT00666757 · 2008-05-01 · 1 site observation
COMPLETED
Escitalopram in Adult Patients With Major Depressive DisorderNCT00668525 · 2008-04-01 · 1 site observation
COMPLETED
A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy VolunteersNCT01565330 · 2008-03-01 · 1 site observation
COMPLETED
Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive DisorderNCT00659347 · 2008-03-01 · 1 site observation
TERMINATED
Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With SchizophreniaNCT00654706 · 2008-03-01 · 1 site observation
COMPLETED
A Safety, Efficacy and Tolerability Study of SEP-225289NCT00584974 · 2007-12-01 · 1 site observation
COMPLETED
Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver DiseaseNCT00535145 · 2007-10-01 · 1 site observation
COMPLETED
Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to PaliperidoneNCT00535132 · 2007-10-01 · 1 site observation
COMPLETED
A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) PatientsNCT00536471 · 2007-09-01 · 1 site observation
COMPLETED
Proof of Concept Study of Cognitive Improvement in Patients With SchizophreniaNCT00528905 · 2007-08-01 · 1 site observation
COMPLETED
Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderNCT00481195 · 2007-06-01 · 1 site observation
COMPLETED
A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.NCT00775203 · 2007-06-01 · 1 site observation
COMPLETED
Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic PatientsNCT00396214 · 2007-04-01 · 2 site observations
TERMINATED
Study Evaluating Bifeprunox in Patients With Schizophrenia.NCT00366327 · 2007-01-01 · 1 site observation
TERMINATED
Switch Study of Existing Atypical Antipsychotics to BifeprunoxNCT00347425 · 2006-12-01 · 1 site observation
COMPLETED
Study Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary EndpointNCT00366704 · 2006-11-01 · 1 site observation
TERMINATED
Open Label Extension Study of BifeprunoxNCT00366171 · 2006-11-01 · 1 site observation
COMPLETED
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive DisorderNCT00384033 · 2006-09-01 · 1 site observation
COMPLETED
Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.NCT00325689 · 2006-07-01 · 1 site observation
COMPLETED
Study Comparing the Affect of Bifeprunox Vs Olanzapine on Weight During the Treatment of Outpatients With Schizophrenia.NCT00380224 · 2006-07-01 · 1 site observation
COMPLETED
Efficacy Study of Early Onset of Antipsychotic Drug Action in SchizophreniaNCT00337662 · 2006-05-01 · 1 site observation
COMPLETED
Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive DisordersNCT00326105 · 2006-04-01 · 1 site observation
COMPLETED
Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive DisorderNCT00320268 · 2006-04-01 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I DisorderNCT00309699 · 2006-04-01 · 1 site observation
COMPLETED
Study Evaluating Desvenlafaxine Sustained-Release (DVS-SR) in Adult Outpatients With Major Depressive DisorderNCT00277823 · 2006-02-01 · 1 site observation
COMPLETED
Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute SchizophreniaNCT00254202 · 2005-11-18 · 1 site observation
COMPLETED
SB-773812 Administered In Adults With SchizophreniaNCT00259870 · 2005-09-01 · 1 site observation
COMPLETED
A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major DepressionNCT00208156 · 2005-05-01 · 1 site observation
COMPLETED
The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive DisorderNCT00107120 · 2005-03-01 · 1 site observation
COMPLETED
Comparison of Escitalopram Combination in Adult Patients With Major Depressive DisorderNCT00109044 · 2005-03-01 · 1 site observation
COMPLETED
A Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia.NCT00111189 · 2005-02-01 · 1 site observation
COMPLETED
Study Of Talnetant Versus Placebo And Risperidone In SchizophreniaNCT00103727 · 2004-12-01 · 1 site observation
COMPLETED
Effect Of Talnetant Versus Risperidone Versus Placebo On Psychotic Symptoms In Schizophrenic PatientsNCT00300963 · 2004-12-01 · 1 site observation
COMPLETED
Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With SchizophreniaNCT00206128 · 2004-11-01 · 1 site observation
COMPLETED
Study Of GW679769 In Major Depressive DisorderNCT00102492 · 2004-10-01 · 1 site observation
COMPLETED
A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive DisorderNCT00191061 · 2004-10-01 · 1 site observation
COMPLETED
A United States Study of Corlux for Psychotic Symptoms in Psychotic Major DepressionNCT00130676 · 2004-09-01 · 1 site observation
COMPLETED
Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective DisorderNCT00090012 · 2004-07-01 · 1 site observation
COMPLETED
A Study to Test the Safety and Tolerability of a New Medication in the Treatment of SchizophreniaNCT00088621 · 2004-07-01 · 1 site observation
COMPLETED
An Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Studies of GalantamineNCT00297414 · 2004-06-01 · 1 site observation
COMPLETED
A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive EpisodeNCT00094432 · 2004-06-01 · 1 site observation
COMPLETED
Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With SchizophreniaNCT00088478 · 2004-06-01 · 1 site observation
COMPLETED
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of SchizophreniaNCT00088634 · 2004-05-01 · 1 site observation
COMPLETED
A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized PatientsNCT00634348 · 2004-04-01 · 1 site observation
COMPLETED
A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive DisorderNCT00368030 · 2004-01-01 · 1 site observation
COMPLETED
Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective DisorderNCT00100776 · 2003-09-01 · 1 site observation
COMPLETED
Long-Term Safety Of DVS-233 SR In Patients With Major Depressive DisorderNCT01309542 · 2003-08-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.